Guilin Sanjin Pharmaceutical Co., Ltd. (002275.SZ)
CNY 13.63
(0.15%)
CNY 13.63
(0.15%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 2.17 Billion CNY | 10.82% |
| 2022 | 1.95 Billion CNY | 12.55% |
| 2021 | 1.74 Billion CNY | 11.15% |
| 2020 | 1.56 Billion CNY | -4.51% |
| 2019 | 1.64 Billion CNY | 3.52% |
| 2018 | 1.58 Billion CNY | -1.94% |
| 2017 | 1.61 Billion CNY | 5.95% |
| 2016 | 1.52 Billion CNY | 11.18% |
| 2015 | 1.37 Billion CNY | -6.45% |
| 2014 | 1.46 Billion CNY | 0.94% |
| 2013 | 1.45 Billion CNY | 10.76% |
| 2012 | 1.31 Billion CNY | 12.89% |
| 2011 | 1.16 Billion CNY | 18.13% |
| 2010 | 983.46 Million CNY | -11.47% |
| 2009 | 1.11 Billion CNY | 12.64% |
| 2008 | 986.15 Million CNY | 10.43% |
| 2007 | 893.04 Million CNY | 11.93% |
| 2006 | 797.85 Million CNY | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q2 | 585.82 Million CNY | 21.39% |
| 2024 Q3 | 506.37 Million CNY | -13.56% |
| 2024 Q1 | 482.58 Million CNY | -10.63% |
| 2023 FY | 2.17 Billion CNY | 10.82% |
| 2023 Q4 | 539.98 Million CNY | 23.39% |
| 2023 Q1 | 715.92 Million CNY | 37.47% |
| 2023 Q2 | 478.23 Million CNY | -33.2% |
| 2023 Q3 | 437.6 Million CNY | -8.5% |
| 2022 Q4 | 520.77 Million CNY | 17.43% |
| 2022 Q3 | 443.48 Million CNY | -7.33% |
| 2022 Q2 | 478.58 Million CNY | -7.41% |
| 2022 Q1 | 516.89 Million CNY | 6.45% |
| 2022 FY | 1.95 Billion CNY | 12.55% |
| 2021 Q3 | 375.75 Million CNY | -16.56% |
| 2021 Q1 | 429.58 Million CNY | -8.33% |
| 2021 Q2 | 450.31 Million CNY | 4.82% |
| 2021 FY | 1.74 Billion CNY | 11.15% |
| 2021 Q4 | 485.56 Million CNY | 29.23% |
| 2020 Q3 | 345.61 Million CNY | -18.41% |
| 2020 Q1 | 328.65 Million CNY | -35.95% |
| 2020 FY | 1.56 Billion CNY | -4.51% |
| 2020 Q4 | 468.61 Million CNY | 35.59% |
| 2020 Q2 | 423.6 Million CNY | 28.89% |
| 2019 Q1 | 377.44 Million CNY | -20.07% |
| 2019 FY | 1.64 Billion CNY | 3.52% |
| 2019 Q4 | 513.08 Million CNY | 52.38% |
| 2019 Q3 | 336.71 Million CNY | -18.51% |
| 2019 Q2 | 413.17 Million CNY | 9.47% |
| 2018 FY | 1.58 Billion CNY | -1.94% |
| 2018 Q4 | 472.2 Million CNY | 32.72% |
| 2018 Q3 | 355.78 Million CNY | -13.45% |
| 2018 Q2 | 411.08 Million CNY | 18.95% |
| 2018 Q1 | 345.6 Million CNY | -35.59% |
| 2017 Q3 | 349.39 Million CNY | -11.32% |
| 2017 Q1 | 336.07 Million CNY | -35.42% |
| 2017 FY | 1.61 Billion CNY | 5.95% |
| 2017 Q4 | 536.55 Million CNY | 53.57% |
| 2017 Q2 | 393.99 Million CNY | 17.24% |
| 2016 Q3 | 331.81 Million CNY | -9.08% |
| 2016 FY | 1.52 Billion CNY | 11.18% |
| 2016 Q4 | 520.4 Million CNY | 56.84% |
| 2016 Q1 | 299.46 Million CNY | -38.19% |
| 2016 Q2 | 364.94 Million CNY | 21.87% |
| 2015 Q2 | 383.86 Million CNY | 71.84% |
| 2015 Q4 | 484.48 Million CNY | 72.98% |
| 2015 FY | 1.37 Billion CNY | -6.45% |
| 2015 Q1 | 223.38 Million CNY | -50.5% |
| 2015 Q3 | 280.08 Million CNY | -27.04% |
| 2014 Q2 | 358.46 Million CNY | 14.32% |
| 2014 FY | 1.46 Billion CNY | 0.94% |
| 2014 Q4 | 451.27 Million CNY | 31.55% |
| 2014 Q3 | 343.03 Million CNY | -4.3% |
| 2014 Q1 | 313.56 Million CNY | -29.82% |
| 2013 Q4 | 446.81 Million CNY | 23.66% |
| 2013 FY | 1.45 Billion CNY | 10.76% |
| 2013 Q1 | 332.06 Million CNY | -15.5% |
| 2013 Q2 | 312.41 Million CNY | -5.92% |
| 2013 Q3 | 361.34 Million CNY | 15.66% |
| 2012 Q2 | 306.33 Million CNY | 6.31% |
| 2012 FY | 1.31 Billion CNY | 12.89% |
| 2012 Q4 | 392.98 Million CNY | 21.26% |
| 2012 Q1 | 288.13 Million CNY | -19.86% |
| 2012 Q3 | 324.09 Million CNY | 5.8% |
| 2011 Q3 | 281.87 Million CNY | -2.35% |
| 2011 Q1 | 231.7 Million CNY | -23.96% |
| 2011 Q2 | 288.64 Million CNY | 24.58% |
| 2011 FY | 1.16 Billion CNY | 18.13% |
| 2011 Q4 | 359.55 Million CNY | 27.56% |
| 2010 Q4 | 304.68 Million CNY | 29.96% |
| 2010 Q3 | 234.44 Million CNY | -1.33% |
| 2010 FY | 983.46 Million CNY | -11.47% |
| 2010 Q1 | 206.71 Million CNY | -45.94% |
| 2010 Q2 | 237.61 Million CNY | 14.95% |
| 2009 Q4 | 382.41 Million CNY | 53.86% |
| 2009 Q3 | 248.55 Million CNY | -20.49% |
| 2009 Q2 | 312.58 Million CNY | 86.88% |
| 2009 FY | 1.11 Billion CNY | 12.64% |
| 2009 Q1 | 167.26 Million CNY | -50.69% |
| 2008 Q3 | 206.67 Million CNY | 0.0% |
| 2008 Q4 | 339.24 Million CNY | 64.15% |
| 2008 FY | 986.15 Million CNY | 10.43% |
| 2007 FY | 893.04 Million CNY | 11.93% |
| 2006 FY | 797.85 Million CNY | 0.0% |